Multiresistant Salmonella typhimurium DT 104 and salmonella bacteraemia

Lancet

Volumn 352, Issue 9124, 1998, Pages 287-288

  Threlfall, E J ^a   Ward, L R ^b   Rowe, B ^b  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIOPHAGE TYPING; HUMAN; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SALMONELLOSIS;

EID: 0032566224     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60261-9     Document Type: Article

References (5)

1. 1 Threlfall EJ, Ward LR, Rowe B. Increasing incidence of resistance to trimethoprim and ciprofloxacin in endemic Salmonella typhimurium in England and Wales. Eurosurueillance 1997; 2: 81-84.
2. 2 Wall PG, Morgan D, Lamden K, et al. A case-control study of infection with an epidemic strain of multiresistant Salmonella typhimurium DT 104 in England and Wales. Comm Dis Rep Rev 1994; 4: R130-R135.
3. 3 CDC. Multidrug-resistant Salmonella serotype typhimurium - United States. Morb Mortal Wkly Rep 1997; 46: 308-10.
4. 4 Glynn MK, Bopp C, Dewitt W, Dabney P, Mokhtar M, Angulo F. Emergence of multidrug-resistant Salmonella enterica serotype Typhimurium DT104 infections in the United States. N Engl J Med 1998; 19: 1333-38.
5. 5 Miller MA. Widespread emergence in the United States of multiple drug-resistant type of Salmonella typhimurium. FDA Veterinarian 1997; 12 (4): 5-6.